Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-30 Purchase | 2026-07-06 4:06 pm | Absci Corp | ABSI | Szela Mary T Director | 12,900 | $11.54 | $148,866 | 21,300 (Direct) | View |
| 2026-05-15 Purchase | 2026-05-18 4:42 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 39,682 | $2.59 | $102,776 | 1,065,215 (Direct) | View |
| 2026-03-11 Sale | 2026-03-20 4:25 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 20,302 | $3.9101 | $79,383 | 752,987 (Direct) | View |
| 2026-02-23 Purchase | 2026-02-23 4:08 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 30,487 | $4.1 | $124,997 | 773,289 (Direct) | View |
| 2025-01-29 Purchase | 2025-01-31 5:54 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 10,040 | $5.1548 | $51,754 | 444,259 (Direct) | View |
| 2025-01-27 Purchase | 2025-01-29 6:15 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 9,542 | $5.2717 | $50,303 | 674,219 (Direct) | View |
| 2024-09-12 Purchase | 2024-09-13 5:43 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 14,815 | $5.0867 | $75,359 | 384,677 (Direct) | View |
| 2024-09-10 Purchase | 2024-09-12 7:06 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 5,000 | $4.97 | $24,850 | 369,862 (Direct) | View |
| 2023-06-16 Sale | 2023-06-16 4:00 pm | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 2,071 | $0 | $0 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-30 Option Award | 2026-07-01 4:04 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 3,990 | $3.87 | 1,077,683 (Direct) | View |
| 2025-12-31 Ownership | 2026-07-01 4:03 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 2,100 | $4.38 | 1,023,826 (Direct) | View |
| 2024-12-31 Ownership | 2026-07-01 4:03 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 3,530 | $4.26 | 1,023,826 (Direct) | View |
| 2025-06-30 Ownership | 2026-07-01 4:03 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 2,848 | $4.23 | 1,023,826 (Direct) | View |
| 2026-06-04 Option Award(A) | 2026-06-15 8:40 pm | N/A 2036-06-03 | Absci Corp | ABSI | Szela Mary T Director | 41,600 | $0 | 41,600 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 9:59 pm | N/A 2036-06-03 | Absci Corp | ABSI | Szela Mary T Director | 49,900 | $0 | 49,900 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-04 6:30 pm | N/A 2036-06-03 | Kura Oncology Inc. | KURA | Szela Mary T Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-11-24 Option Award | 2025-11-25 3:55 pm | N/A 2035-11-23 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 800,000 | $0 | 2,320,984 (Direct) | View |
| 2025-07-07 Option Award | 2025-07-09 4:46 pm | N/A 2035-07-06 | Absci Corp | ABSI | Szela Mary T Director | 178,400 | $0 | 178,400 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Kura Oncology Inc. | KURA | Szela Mary T Director | 28,500 | $0 | 28,500 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-19 5:41 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 21,089 | $0 | 465,348 (Direct) | View |
| 2025-01-27 Option Award | 2025-01-29 6:15 pm | N/A 2035-01-26 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 280,000 | $0 | 674,219 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 4:20 pm | N/A 2034-06-19 | Omega Therapeutics Inc. | OMGA | Szela Mary T Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Kura Oncology Inc. | KURA | Szela Mary T Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-14 6:44 pm | N/A 2034-02-12 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 373,649 | $0 | 653,612 (Direct) | View |
| 2023-08-14 Option Award | 2023-08-15 4:48 pm | N/A 2033-08-13 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 172,500 | $0 | 172,500 (Direct) | View |
Ownership | 2023-08-15 4:46 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 0 | $0 | 906,895 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | Szela Mary T Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 5:02 pm | N/A 2033-05-30 | Kura Oncology Inc. | KURA | Szela Mary T Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:47 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 2,071 | $0 | 2,071 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 4:49 pm | N/A 2032-06-20 | Kura Oncology Inc. | KURA | Szela Mary T Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:10 pm | N/A 2032-06-07 | Omega Therapeutics Inc. | OMGA | Szela Mary T Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:30 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 20,500 | $0 | 20,500 (Direct) | View |